| [1] |
Jemal A, Bray F, Center MM, et al. Global Cancer statistics[J]. CA Cancer J Clin, 2011, 61(2): 69-90. doi: 10.3322/caac.v61:2
|
| [2] |
Crowley E, Di Nicolantonio F, Loupakis F, et al. Liquid biopsy: Crowley E, Di Nicolantonio F, Loupakis F, et al. Liquid biopsy: monitoring cancer-genetics in the blood[J]. Nat Rev Clin Oncol, 2013, 10(8): 472-84. doi: 10.1038/nrclinonc.2013.110
|
| [3] |
van de Stolpe A, Pantel K, Sleijfer SA, et al. Circulating tumor cell isolation and diagnostics: toward routine clinical use[J]. Cancer Res, 2011, 71(18): 5955-60. doi: 10.1158/0008-5472.CAN-11-1254
|
| [4] |
Forshew T, Murtaza M, Parkinson C, et al. Noninvasive identification and monitoring of Cancer mutations by targeted deep sequencing of plasma DNA[J]. Sci Transl Med, 2012, 4(136): 136ra68.
|
| [5] |
Ghossein RA, Bhattacharya S, Rosai J. Molecular detection of micrometastases and circulating tumor cells in solid tumors[J]. Clin Cancer Res, 1999, 5(8): 1950-60.
|
| [6] |
Tan SJ, Yobas L, Lee GY, et al. Microdevice for the isolation and enumeration of Cancer cells from blood[J]. Biomed Microdevices, 2009, 11(4): 883-92. doi: 10.1007/s10544-009-9305-9
|
| [7] |
Mohamed H, Murray M, Turner JN, et al. Isolation of tumor cells using size and deformation[J]. J Chromatogr A, 2009, 1216(47): 8289-95. doi: 10.1016/j.chroma.2009.05.036
|
| [8] |
Nagrath S, Sequist LV, Maheswaran S, et al. Isolation of rare circulating tumour cells in Cancer patients by microchip technology [J]. Nature, 2007, 450(7173): 1235-9. doi: 10.1038/nature06385
|
| [9] |
Stott SL, Lee RJ, Nagrath S, et al. Isolation and characterization of circulating tumor cells from patients with localized and metastatic prostate cancer[J]. Sci Transl Med, 2010, 2(25): 14. https://www.ncbi.nlm.nih.gov/pubmed/20424012
|
| [10] |
Hsieh HB, Marrinucci D, Bethel K, et al. High speed detection of circulating tumor cells[J]. Biosens Bioelectron, 2006, 21(8): 1893-9.
|
| [11] |
Alix-Panabières C. EPISPOT assay: detection of viable DTCs/ CTCs in solid tumor patients[J]. Recent Results Cancer Res, 2012, 195(7): 69-76.
|
| [12] |
Uen YH, Lin SR, Wu CH, et al. Clinical significance of MUC1 and c-Met RT-PCR detection of circulating tumor cells in patients with gastric carcinoma[J]. Clin Chim Acta, 2006, 367(7): 55-61. https://www.ncbi.nlm.nih.gov/pubmed/16403482
|
| [13] |
Dardaei L, Shahsavani R, Ghavamzadeh A, et al. The detection of disseminated tumor cells in bone marrow and peripheral blood of gastric cancer patients by multimarker (CEA, CK20, TFF1 and MUC2) quantitative real-time PCR[J]. Clin Biochem, 2011, 44(4): 325-30. doi: 10.1016/j.clinbiochem.2010.11.005
|
| [14] |
Wu CH, Lin SR, Hsieh JS, et al. Molecular detection of disseminated tumor cells in the peripheral blood of patients with gastric cancer: Evaluation of their prognostic significance[J]. Dis Markers, 2006, 22(3): 103-9. doi: 10.1155/2006/281315
|
| [15] |
Cui L, Lou YR, Zhang XJ, et al. Detection of circulating tumor cells in peripheral blood from patients with gastric cancer using piRNAs as markers[J]. Clin Biochem, 2011, 44(13): 1050-7. doi: 10.1016/j.clinbiochem.2011.06.004
|
| [16] |
Zheng Y, Cui L, Sun W, et al. MicroRNA-21 is a new marker of circulating tumor cells in gastric cancer patients[J]. Cancer Biomark, 2012, 10(2): 71-7.
|
| [17] |
Hiraiwa K, Takeuchi H, Hasegawa H, et al. Clinical significance of circulating tumor cells in blood from patients with gastrointestinal cancers[J]. Ann Surg Oncol, 2008, 15(11): 3092-100. doi: 10.1245/s10434-008-0122-9
|
| [18] |
Matsusaka S, Chìn K, Ogura M, et al. Circulating tumor cells as a surrogate marker for determining response to chemotherapy in patients with advanced gastric cancer[J]. Cancer Sci, 2010, 101(4): 1067-71. doi: 10.1111/j.1349-7006.2010.01492.x
|
| [19] |
Pituch-Noworolska A, Kolodziejczyk P, Kulig JA, et al. Circulating tumour cells and survival of patients with gastric cancer[J]. Anticancer Res, 2007, 27(1B): 635-40.
|
| [20] |
Friederichs J, Gertler R, Rosenberg R, et al. Prognostic impact of CK-20-positive cells in peripheral venous blood of patients with gastrointestinal carcinoma[J].World J Surg, 2005, 29(4): 422-8. doi: 10.1007/s00268-004-7662-3
|
| [21] |
Seo JH, Choi CW, Kim BS, et al. Follow-up study of peripheral blood carcinoembryonic antigen mRNA using reverse transcription-polymerase chain reaction as an early marker of clinical recurrence in patients with curatively resected gastric cancer [J]. Am J Clin Oncol, 2005, 28(1): 24-9. doi: 10.1097/01.coc.0000139018.47930.a5
|
| [22] |
Mimori K, Fukagawa T, Kosaka Y, et al. A large-scale study of MT1-MMP as a marker for isolated tumor cells in peripheral blood and bone marrow in gastric Cancer cases[J]. Ann Surg Oncol, 2008, 15(7): 2934-42. https://www.researchgate.net/publication/51432008_A_Large-Scale_Study_of_MT1-MMP_as_a_Marker_for_Isolated_Tumor_Cells_in_Peripheral_Blood_and_Bone_Marrow_in_Gastric_Cancer_Cases
|
| [23] |
Vasioukhin V, Anker P, Maurice P, et al. Point mutations of the N-ras gene in the blood plasma DNA of patients with myelodysplastic syndrome or acute myelogenous leukaemia[J]. Br J Haematol, 1994, 86(9): 774-9. https://www.researchgate.net/publication/227977209_Point_mutation_of_the_N-ras_gene_in_the_blood_plasma_DNA_of_patients_with_Myelodysplastic_syndrome_or_acute_myelogenous_leukaemia
|
| [24] |
Sorenson GD, Pribish DM, Valone FH, et al. Soluble normal and mutated DNA sequences from single-copy genes in human blood [J]. Cancer Epidemiol Biomarkers Prev, 1994, 3(9): 67-71. http://www.sigmaaldrich.com/catalog/papers/8118388
|
| [25] |
Choi JJ, Reich CF, Pisetsky DS. The role of macrophages in the in vitro Generation of extracellular DNA from apoptotic and necrotic cells[J]. Immunology, 2005, 115(1): 55-62. doi: 10.1111/imm.2005.115.issue-1
|
| [26] |
Trejo-Becerril C, Pérez-Cárdenas E, Taja-Chayeb L, et al. Cancer progression mediated by horizontal gene transfer in an in vivo model [J]. PLoS One, 2012, 7(12): e52754. doi: 10.1371/journal.pone.0052754
|
| [27] |
Garcia-Olmo DC, Dominguez C, Garcia-Arranz M, et al. Cell-Free nucleic acids circulating in the plasma of colorectal cancer patients induce the oncogenic transformation of susceptible cultured cells [J]. Cancer Res, 2010, 70(2): 560-7. doi: 10.1158/0008-5472.CAN-09-3513
|
| [28] |
Stroun M, Lyautey J, Lederrey C, et al. About the possible origin and mechanism of circulating DNA - Apoptosis and active DNA release[J]. Clin Chim Acta, 2001, 313(1/2): 139-42.
|
| [29] |
Diaz J, Williams RT, Wu J, et al. The molecular evolution of acquired resistance to targeted EGFR blockade in colorectal cancers [J]. Nature, 2012, 486(744): 537-40.
|
| [30] |
Misale S, Yaeger R, Hobor S, et al. Emergence of KRAS mutations and acquired resistance to anti-EGFR therapy in colorectal cancer [J]. Nature, 2012, 486(744): 532-6.
|
| [31] |
Lee TL, Leung WK, Chan MW, et al. Detection of gene promoter hypermethylation in the tumor and serum of patients with gastric carcinoma[J]. Clin Cancer Res, 2002, 8(6): 1761-6.
|
| [32] |
Ling ZQ, Lv P, Lu XX, et al. Circulating methylated XAF1 DNA indicates poor prognosis for gastric cancer[J]. PLoS One, 2013, 8 (6): e67195. doi: 10.1371/journal.pone.0067195
|
| [33] |
Park KU, Lee HE, Park DJ, et al. MYC quantitation in cell-free plasma DNA by real-time PCR for gastric cancer diagnosis[J]. Clin Chem Lab Med, 2009, 47(5): 530-6. https://www.ncbi.nlm.nih.gov/pubmed/19302034
|
| [34] |
Lee HE, Park KU, Yoo SB, et al. Clinical significance of intratumoral HER2 heterogeneity in gastric cancer[J]. Eur J Cancer, 2013, 49(6): 1448-57. doi: 10.1016/j.ejca.2012.10.018
|
| [35] |
Kopreski MS, Benko FA, Kwak LW, et al. Detection of tumor messenger RNA in the serum of patients with malignant melanoma [J]. Clin Cancer Res, 1999, 5(8): 1961-5. https://www.researchgate.net/publication/12827112_Detection_of_tumor_messenger_RNA_in_serum_of_patients_with_malignant_melanoma
|
| [36] |
Lo KW, Lo YM, Leung SF, et al. Analysis of cell-free Epstein-Barr virus associated RNA in the plasma of patients with nasopharyngeal carcinoma[J]. Clin Chem, 1999, 45(8 Pt 1): 1292-4. https://www.ncbi.nlm.nih.gov/pubmed/10430801
|
| [37] |
Tani N, Ichikawa D, Ikoma D, et al. Circulating cell-free mRNA in plasma as a tumor marker for patients with primary and recurrent gastric cancer[J]. Anticancer Res, 2007, 27(2): 1207-12. https://www.researchgate.net/profile/Norimasa_Miura/publication/6365121_Circulating_cell-free_mRNA_in_plasma_as_a_tumor_marker_for_patients_with_primary_and_recurrent_gastric_cancer/links/09e4150599f05d0b99000000.pdf?origin=publication_list
|
| [38] |
Kang Y, Zhang J, Sun P, et al. Circulating cell-free human telomerase reverse transcriptase mRNA in plasma and its potential diagnostic and prognostic value for gastric cancer[J]. Int J Clin Oncol, 2013, 18(3): 478-86. doi: 10.1007/s10147-012-0405-9
|
| [39] |
Simpson RJ, Jensen SS, Lim JW. Proteomic profiling of exosomes: current perspectives[J]. Proteomics, 2008, 8(19): 4083-99. doi: 10.1002/pmic.v8:19
|
| [40] |
Tsujiura M, Ichikawa D, Komatsu S, et al. Circulating microRNAs in plasma of patients with gastric cancers[J]. Br J Cancer, 2010, 102 (7): 1174-9. doi: 10.1038/sj.bjc.6605608
|
| [41] |
Konishi H, Ichikawa D, Komatsu S, et al. Detection of gastric cancer-associated microRNAs on microRNA microarray comparing pre- and post-operative plasma[J]. Br J Cancer, 2012, 106(4): 740-7. doi: 10.1038/bjc.2011.588
|
| [42] |
Arita T, Ichikawa D, Konishi H, et al. Circulating long non-coding RNAs in plasma of patients with gastric cancer[J]. Anticancer Res, 2013, 33(8): 3185-93. https://www.researchgate.net/publication/253340124_Circulating_Long_Non-coding_RNAs_in_Plasma_of_Patients_with_Gastric_Cancer
|
点击查看大图
下载:
